Amiodarone in ventricular arrhythmias: still a valuable resource?

Amiodarone in ventricular arrhythmias: still a valuable resource?

Ventricular arrhythmias still represent an important cause of morbidity and mortality, especially in patients with heart failure and reduced left ventricular ejection fraction. Amiodarone is a Class III Vaughan-Williams anti-arrhythmic drug widely used in ventricular arrhythmias for its efficacy...

Full description

Bibliographic Details
Main Authors: Luigi Pannone, Giuseppe D’Angelo, Simone Gulletta, Giulio Falasconi, Luigia Brugliera, Antonio Frontera, Lorenzo Cianfanelli, Luca Baldetti, Paolo Ossola, Francesco Melillo, Gabriele De Blasi, Lorenzo Malatino, Giovanni Landoni, Alberto Margonato, Paolo Della Bella, Daniele Zacchetti, Pasquale Vergara
Format: Article
Language:English
Published: IMR Press 2021-12-01
Series:Reviews in Cardiovascular Medicine
Subjects:
amiodarone
heart failure
ventricular tachycardia
catheter ablation
pharmacology
Online Access:https://rcm.imrpress.com/EN/10.31083/j.rcm2204143

Internet

https://rcm.imrpress.com/EN/10.31083/j.rcm2204143

Similar Items